Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer

Neoadjuvant chemoradiation did not increase survival, local control or late toxicity compared with short-course radiotherapy alone.